HonorHealth Research and Innovation Institute
Scottsdale, AZ
Accepting patients
MOMENTUM
A Phase 2, Open-Label, Single-Arm, Multicenter Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Subjects With Relapsed/Refractory Multiple Myeloma
- IKZF1/3
- Phase 2